Mounjaro, a potent dual GIP/GLP-1 receptor agonist, provides comprehensive incretin-based glucose control that encompasses and exceeds the effects of Januvia, a DPP-4 inhibitor
It works as a GLP-1 receptor agonist
If youre instead replacing them, its likely an expensive try
In the study of JANUVIA as add-on combination therapy with metformin and rosiglitazone (Table 1), through Week 54 the adverse reactions reported regardless of investigator assessment of causality in 5% of patients treated with JANUVIA and more commonly than in patients treated with placebo were: upper respiratory tract infection (JANUVIA, 15.5%
Although some progress has been made in gene therapy research, the current technology is still not mature
(1) This 16 amino acid peptide reportedly retains the disulfide bond between cysteine residues at positions analogous to Cys182 and Cys189 in the intact hGH molecule, corresponding to positions 7 and 14 within the peptide